Skip to main content
SpringerLink
Log in

Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, Orikasa S, Akasaka R, Chiba T, Uesugi N, Sugai T, Matsumoto T (2016) Dabigatran-induced esophagitis: the prevalence and endoscopic characteristics. J Gastroenterol Hepatol 31(3):610–614

    Article  CAS  Google Scholar 

  2. Matsuura H, Suto K, Yasuhara H, Hata H (2018) Longitudinal sloughing mucosal casts: dabigatran-induced oesophagitis. Eur Heart J 39(36):3400

    Article  Google Scholar 

  3. Cox R, Roche E, Fairley S (2016) Novel oral anticoagulant drugs and severe oesophagitis dissecans. Intern Med J 46(12):1456–1457

    Article  CAS  Google Scholar 

  4. Okada M, Okada K (2012) Exfoliative esophagitis and esophageal ulcer induced by dabigatran. Endoscopy 44(Suppl 2 UCTN):E23–E24

    PubMed  Google Scholar 

  5. Wood M, Shaw P (2015) Pradaxa-induced esophageal ulcer. BMJ Case Rep pii: bcr2015211371

  6. Zimmer V, Casper M, Lammert F (2014) Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma. Endoscopy 46(Suppl 1 UCTN):E273–E274

    PubMed  Google Scholar 

  7. Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C (2005) Perspectives on the use of data mining in pharmacovigilance. Drug Saf 28(11):981–1007

    Article  CAS  Google Scholar 

  8. Clemens A, Strack A, Noack H, Konstantinides S, Brueckmann M, Lip GYH (2014) Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions? Ann Med 46(8):672–678

    Article  CAS  Google Scholar 

  9. Staerk L, Gislason GH, Lip GY, Fosbol EL, Hansen ML, Lamberts M, Bonde AN, Torp-Pedersen C, Olesen JB (2015) Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study. Europace 17(8):1215–1222. https://doi.org/10.1093/europace/euv119

    Article  PubMed  Google Scholar 

  10. Desai JC, Chatterjee P, Friedman K, Aisenberg J (2016) Incidence and clinical presentation of gastrointestinal bleeding in atrial fibrillation patients taking direct oral anticoagulants. Am J Gastroenterol Suppl 3:13–21

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada

    Donald Mattison, Christopher Gravel & Daniel Krewski

  2. Risk Sciences International, Hilton Head Island, SC, USA

    Donald Mattison

  3. Risk Sciences International, Ottawa, ON, Canada

    Christopher Gravel & Daniel Krewski

  4. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada

    Christopher Gravel & Laurent Azoulay

  5. McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada

    Daniel Krewski

  6. Centre for Clinical Epidemiology, Lady Davis Institute, 3755 Cote Ste-Catherine, H-492, Montreal, QC, H3T 1E2, Canada

    Laurent Azoulay & Antonios Douros

  7. Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada

    Laurent Azoulay

  8. Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland, UK

    Blánaid Hicks

  9. Department of Medicine, McGill University, Montreal, QC, Canada

    Antonios Douros

  10. Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    Antonios Douros

Authors
  1. Donald Mattison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Gravel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Krewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laurent Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Blánaid Hicks
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonios Douros
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.D. drafted the manuscript. D.M., C.G., D.K., L.A., B.H., and A.D. conceived and designed the study. D.M., C.G., D.K., L.A., B.H., and A.D. analysed and interpreted data. D.M., C.G., D.K., L.A., B.H., and A.D. critically revised the manuscript for important intellectual content. D.M., C.G., and A.D. performed the statistical analysis. A.D. supervised the study. A.D. is the guarantor of this work.

Corresponding author

Correspondence to Antonios Douros.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mattison, D., Gravel, C., Krewski, D. et al. Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis. Eur J Clin Pharmacol 76, 1045–1047 (2020). https://doi.org/10.1007/s00228-020-02877-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-020-02877-1

Search

Navigation